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Male sexual differentiation and development proceed under direct control of androgens. Androgen action is 
mediated by the intracellular androgen receptor, which belongs to the superfamily of ligand-dependent tran- 
scription factors. In the X-linked androgen insensitivity syndrome, defects in the androgen receptor gene have 
prevented the normal development of both internal and external male structures in 46,XY individuals. The 
complete form of androgen insensitivity syndrome is characterized by 46,XY karyotype, external female pheno- 
type, intra-abdominal testes, absence of uterus and ovaries, blindly ending vagina, and gynecomastia. There is 
also a group of disorders of androgen action that result from partial impairment of androgen receptor function. 
Clinical indications can be abnormal sexual development of individuals with a predominant male phenotype with 
severe hypospadias and micropenis or of individuals with a predominantly female phenotype with cliteromegaly, 
ambiguous genitalia, and gynecomastia. Complete or gross deletions of the androgen receptor gene have not 
been frequently found in persons with the complete androgen insensitivity syndrome, whereas point mutations at 
several different sites in exons 2--8 encoding the DNA- and androgen-binding domain have been reported in both 
partial and complete forms of androgen insensitivity, with a relatively high number of mutations in two clusters 
in exons 5 and 7. The number of mutations in exon 1 is extremely ow, and no mutations have been reported in 
the hinge region, located between the DNA-binding domain and the ligand-binding domain. The X-linked 
condition of spinal and bulbar muscle atrophy (Kennedy's disease) is characterized by a progressive motor 
neuron degeneration associated with signs of androgen insensitivity and infertility. The molecular cause of spinal 
and bulbar muscle atrophy is an expanded length (>40 residues) of one of the polyglutamine stretches in the 
N-terminal domain of the androgen receptor. (Steroids 61:172-175, 1996) 
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Introduction 
Androgens (testosterone and 5e~-dihydrotestosterone) play a 
crucial role in various stages of male development ~ by in- 
teracting in their target cells with androgen receptors to 
regulate gene expression. The androgen receptor belongs to 
a large family of DNA-binding zinc-finger proteins, which 
also includes the other steroid hormone receptors, thyroid 
hormone receptors, retinoid receptors, and an increasing 
number of orphan receptors. 2 During male sexual differen- 
tiation specific roles are played by testosterone and 5a- 
dihydrotestosterone, Initially testosterone is the active hor- 
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mone with respect o development of the Wolffian duct- 
derived structures such as epididymis, vas deferens, seminal 
vesicles, and the ejaculatory duct. In contrast with the de- 
velopment of the Wolffian ducts, masculinization of the 
external genitalia and the development of the urogenital 
sinus into the urethra and the prostate require the action of 
5o~-dihydrotestosterone. 5o~-Dihydrotestosterone is actively 
formed from testosterone by the steroid 5a-reductase type 2 
enzyme, which is specifically expressed in the urogenital 
sinus and urogenital tubercle.1 
In the X-linked androgen insensitivity syndrome, defects 
in the androgen receptor gene prevent he normal develop- 
ment of both internal and external male structures in 46,XY 
individuals. The rare X-linked condition of spinal and bul- 
bar muscular atrophy is characterized by a progressive de- 
generation of motor neurons and is sometimes associated 
with signs of androgen insensitivity and infertility. 
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Cloning and characterization f eDNA encoding the hu- 
man androgen receptor and the elucidation of the organiza- 
tion of the human androgen receptor gene have greatly in- 
creased our knowledge of the molecular structure of the 
human androgen receptor protein. 3-6 The gene is located on 
the X-chromosome and encompasses >90 kilobases (7-9) 
with the protein coding region divided over eight exons. The 
sequence ncoding the N-terminal domain is represented by 
one large exon (exon 1), the DNA-binding domain is en- 
coded by exons 2 and 3, and the information for the steroid- 
binding domain distributed over five exons (exons 4-8). 
The N-terminal domain of the human androgen receptor is 
characterized by the presence of several homopolymeric 
amino acid stretches. Io
The hormone-binding domain is constituted by approxi- 
mately 250 amino acid residues in the C-terminal region. 
The human androgen receptor is functionally active without 
the hormone-binding domain in that deletion of this domain 
leads to a constitutively active androgen receptor protein, 
with wild type trans-activation capacity in the absence of 
hormone. J 1 In contrast, almost he entire N-terminal domain 
is necessary for full transcriptional ctivity. 12 
The human androgen receptor is a phosphoprotein a d is 
additionally phosphorylated upon hormone binding. ~ 3 Phos- 
phorylation of the androgen receptor occurs mainly in a 
region spanning the first 300 amino acid residues, located in 
the N-terminal transactivation domain, and only serine resi- 
dues have been found to be phosphorylated. ~4'~5 
Androgen receptor abnormalities 
In this overview we will focus on the molecular structure of 
the androgen receptor in subjects with the androgen insen- 
sitivity syndrome and in patients with Kennedy's yndrome 
(X-linked spinal and bulbar muscular atrophy). Throughout 
the text, the numbering of the different codons is based on 
a total number of 910 amino acid residues in the human 
androgen receptor (20 glutamine and 16 glycine residues). 
Androgen receptor abnormalities in the androgen 
insensitivity syndrome 
Only a few cases have been reported with partial or com- 
plete deletion of the androgen receptor gene, indicating the 
relative low frequency of this type of androgen receptor 
defect. ~6-18 Most individuals in the reported cases are com- 
pletely androgen resistant. There has been no report of pos- 
sible mutations in the androgen receptor promoter region or 
in the 5'- and 3'-untranslated regions of the gene. 
We have detected a single nucleotide insertion (codon 
42, C insertion) and a single nucleotide deletion (codon 263, 
A deletion) in exon 1 in individuals with the complete an- 
drogen insensitivity syndrome (Figure 1). Both mutations 
caused frameshifts resulting in premature stop codons at 
positions 171 and 292, respectively. In both cases androgen 
receptor protein expression was undetectable. Another mu- 
tation in exon 1 results in a premature stop codon at position 
493. 
Mutations in the DNA-binding domain 
In total 24 different mutations in the DNA-binding domain 
(exons 2 and 3) have been published 17'~8 (Figure 2). Eleven 
PA lS  
1 
I I 




M733V / M7711 
I I I II l lllgosr 
As64D , I I I  l~"nt 
R606H I I 
D686H F755L R846C 
W742R R822X 
R743Q 
Figure 1 Schematic representation of the localization of andro- 
gen receptor mutations detected in Rotterdam in patients with 
the complete (CAIS) and partial (PALS) form of androgen insen- 
sitivity. Amino acid residues are indicated as one-letter symbols. 
nt, nucleotide. 
mutations were observed in the first zinc cluster and thirteen 
in the second zinc cluster. 
In genital skin fibroblasts from a subject with a severe 
form of the X-linked Reifenstein syndrome (partial andro- 
gen insensitivity) we detected ifferential pre-mRNA splic- 
ing due to a genomic deletion involving the intron 2 branch 
point 19 and resulting in 92% aberrant splicing of wild-type 
transcript. The mutant ranscript encodes an androgen re- 
ceptor protein lacking the second zinc finger of the DNA- 
binding domain, is unable to activate transcription, and does 
not influence the transactivating properties of the wild-type 
androgen receptor. A complete deletion of exon three has 
also been reported in a patient with complete androgen in- 
sensitivity. 16-~ 8
Mutations in the androgen-binding domain 
Several functional and structural aspects have been ascribed 
to exon 4, which harbors part of a highly conserved nucleo- 
plasmin like nuclear localization signal, the hinge region, 
and part of the steroid-binding domain. 2° Therefore, muta- 
tions in exon 4 could affect different functions of the an- 
drogen receptor. All reported mutations to date in exon 4 are 
located in the part of the exon that encodes the N-terminal 
region of the steroid-binding domain. In one patient with the 
complete form of androgen insensitivity we have detected a 
G to T mutation on position 1 in the splice donor site of 
intron 4, 2~ leading to abnormal androgen receptor mRNA 
splicing. The mutant receptor was unable to bind androgens 
and did not activate transcription of an androgen-regulated 
reporter gene construct. 2~ In two unrelated individuals with 
the complete form of androgen insensitivity we have found 
two different point mutations at the same nucleotide in 
codon 686 (aspartic acid) of exon 420- (Figure 1). Both mu- 
tant androgen receptors displayed the same altered binding 
characteristics and were devoid of transactivation activity in 
the presence of physiological hormone concentrations. 22 
Exon 5 forms an essential part of the steroid-binding 
domain of the androgen receptor. We have detected five 
different mutations in exon 5, of which the M733V and 
M736T mutations were found in patients with the partial 
form of the androgen insensitivity syndrome (Figure 1). In 
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Figure 2 Location of the different amino acid substitutions in the DNA-binding domain due to point mutations in exons 2 and 3 and 
two deletions of a codon in the androgen receptor gene of individuals with complete (CAIS) or partial (PALS) androgen insensitivity. 17'18 
Amino acid residues are indicated as three-letter symbols. 
exon 5 a total of 33 point mutations in 20 different codons 
17 18 has been reported ' (unpublished observations; Figure 1). 
Two clusters of mutations are localized in exon 5 between 
codons 723-732 and 740-757 in the androgen receptor gene 
of patients with the complete androgen insensitivity syn- 
drome. We have found three mutations (W742R; R743Q; 
F755L) located in the second cluster (Figure 1). 
The twelve reported mutations in exon 6 in eleven dif- 
ferent codons have been found in androgen-insensitive in- 
dividuals with the complete form (7 instances) and the par- 
tial form (5 instances) of the syndrome. 17'18 
For exon 7, thirteen mutations in eight different codons 
have been reported in patients with the complete androgen 
insensitivity syndrome, and seven mutations in patients with 
partial androgen insensitivity 17'18 (unpublished observa- 
tions; Figure 1). In addition in a patient with the complete 
syndrome we have found an insertion of one nucleotide in 
codon 839 causing a frameshift and resulting in a premature 
stop codon (Figure 1). From mutational nalysis tudies it is 
known that this kind of receptor t uncation completely abol- 
ishes hormone binding and transcriptional ctivity. ~ 
In total thirteen mutations in exon 8 have been reported. 
Eight mutations were found in subjects with the complete 
form of androgen insensitivity and five in subjects with the 
part ia l  fo rm 17'is (unpublished observations; Figure 1). 
Androgen receptor abnormalities in spinal and 
buibar muscular atrophy 
An unique example of tissue-specific effects of a defective 
androgen receptor is Kennedy's yndrome. This rare, X- 
linked motor neuron disease becomes manifest in men be- 
tween the age of 30 and 50 and is characterized by a pro- 
gressive spinal and bulbar muscular atrophy associated with 
signs of androgen insensitivity and infertility. 23-25 The 
length of the polyglutamine stretch in the androgen receptor 
in all investigated Kennedy's yndrome patients ranges be- 
tween 40 and 62. 26 
We have investigated the effect of an expanded polyglu- 
tamine stretch and also a completely deleted glutamine 
stretch on the transactivation function of the androgen re- 
ceptor in a model system. For this purpose the androgen 
receptor constructs were expressed after cotransfection of
COS cells with a reporter gene construct containing either 
the mouse mammary tumor virus ,Eromoter or the prostate- 
specific antigen (PSA) promoterf 7 In these experiments a 
2-fold reduction in transcription activation was observed 
with both reporter constructs and the androgen receptor with 
48 glutamine residues. Complete deletion of the glutamine 
stretch resulted in a significant increase in transcriptional 
regulation only with the PSA reporter construct. 28The dif- 
ferences could not be explained by differences in the level 
of receptor protein expression. In similar studies Mhatre et 
al. e9 also found that an androgen receptor with an expanded 
polyglutamine stretch transactivates subnormally. Whether 
doubling of the length of the polyglutamine stretch directly 
affects motor neuron function is still unclear; it is possible 
that a change in the structural constraints on the N-terminal 
domain could result in a modified interaction with motor 
neuron-specific transcription factors and consequently in an 
altered assembly of the transcription i itiation complex. 3° 
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In conclusion, at least two pathological situations are 
associated with androgen resistance due to abnormal andro- 
gen receptor structure and function: androgen insensitivity 
syndrome and spinal and bulbar muscular atrophy. These in 
vivo situations provide the opportunity to correlate receptor 
alterations with impairment of its physiological function, 
which may add new perspectives to our understanding of
the role of the androgen receptor in androgen action. 
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